As part of the original planning for the Jobst Vascular Center, the vascular registry was established to enter clinical and financial data about JVC patients cared for at The Toledo Hospital. Programming and format development for the registry lasted for nearly seven months during 1992.

Since 1992, the registry has undergone several programming and format changes to streamline its many features and provide useful reports to the JVC family of care providers and researchers. Through June 2003, the registry contained more than 9,000 patients with more than 15,000 episodes of care.

Julia Burrows, a JVC intern entering medical school at Wright State University, and Dennis Wojnarowski, lead database coordinator, diligently research the JVC Registry for data to support an upcoming research project.

Among the many values of such an effort is the creation of the largest clinical vascular treatment database with single - institution quality control in the United States Data collected through the registry is used to assess outcomes and the cost effectiveness of various treatments of vascular disease.

The JVC Vascular Registry has recently been expanded to include entry of the indications and results of all endovascular (catheter-based) treatment of vascular conditions regardless of which treating-physician specialty is responsible for the procedure. Thus the ProMedica Health System achieves central registry data acquisition for quality assurance review. This process is intended to help assure patient benefit in the application of new technology.

Goals for the JVC Registry include:

• Describe the natural history of vascular diseases and the course after various forms of treatment
• Provide retrospective data about cost and benefit of various forms of vascular disease treatment
• Serve as a reliable quality assurance instrument in evaluation of the results of treatment
• Facilitate clinical research protocols by providing an existing mechanism for data acquisition and management
• Provide a description of activity in support of hospital resources allocation or in relationships with third party payers, managed health care systems, and government agencies